A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

NCT02612662 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis (NASH)

Interventions

DRUG: AZD4076
DRUG: Placebo

Sponsor

AstraZeneca